Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Solventum Corporation, IDEXX Laboratories or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Solventum Corporation, IDEXX Laboratories and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Solventum Corporation, IDEXX Laboratories and Inc.

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Latest Health Care Equipment & Supplies and Solventum Corporation, IDEXX Laboratories, Inc. Stock News

As of July 31, 2026, Solventum Corporation had a $14.8 billion market capitalization, compared to the Health Care Equipment & Supplies median of $337.2 million. Solventum Corporation’s stock is up 7.8% in 2026, up 9.5% in the previous five trading days and up 17.07% in the past year.

Currently, Solventum Corporation’s price-earnings ratio is 10.5. Solventum Corporation’s trailing 12-month revenue is $8.3 billion with a 17.3% net profit margin. Year-over-year quarterly sales growth most recently was -3.0%. Analysts expect adjusted earnings to reach $6.551 per share for the current fiscal year. Solventum Corporation does not currently pay a dividend.

As of July 31, 2026, IDEXX Laboratories, Inc. had a $44.1 billion market cap, putting it in the 93rd percentile of all stocks. IDEXX Laboratories, Inc.’s stock is down 17.4% in 2026, up 2.7% in the previous five trading days and down 2.28% in the past year.

Currently, IDEXX Laboratories, Inc.’s price-earnings ratio is 41.1. IDEXX Laboratories, Inc.’s trailing 12-month revenue is $4.4 billion with a 24.6% net profit margin. Year-over-year quarterly sales growth most recently was 14.3%. Analysts expect adjusted earnings to reach $14.623 per share for the current fiscal year. IDEXX Laboratories, Inc. does not currently pay a dividend.

How We Compare Solventum Corporation, IDEXX Laboratories and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Solventum Corporation, IDEXX Laboratories and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Solventum Corporation, IDEXX Laboratories and Inc. Growth Grades

Company	Ticker	Growth
Solventum Corporation	SOLV	B
IDEXX Laboratories, Inc.	IDXX	A

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Solventum Corporation has a Growth Score of 73, which is Strong. IDEXX Laboratories, Inc. has a Growth Score of 100, which is Very Strong.

The Growth Grade Winner: IDEXX Laboratories, Inc.

As you can clearly see from the Growth Grade breakdown above, IDEXX Laboratories, Inc. has a more attractive growth grade than Solventum Corporation. For investors who focus solely on how a company is growing relative to other companies in the same industry, IDEXX Laboratories, Inc. could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Solventum Corporation, IDEXX Laboratories and Inc.’s Momentum Grades

Company	Ticker	Momentum
Solventum Corporation	SOLV	B
IDEXX Laboratories, Inc.	IDXX	C

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Solventum Corporation has a Momentum Score of 73, which is Strong. IDEXX Laboratories, Inc. has a Momentum Score of 43, which is Average.

The Momentum Grade Winner: Solventum Corporation

As you can clearly see from the Momentum Grade breakdown above, Solventum Corporation is considered to have stronger momentum compared to IDEXX Laboratories, Inc.. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, Solventum Corporation could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Solventum Corporation, IDEXX Laboratories and Inc.’s Estimate Revisions Grades

Company	Ticker	Earnings Estimate
Solventum Corporation	SOLV	B
IDEXX Laboratories, Inc.	IDXX	C

Earnings estimate revisions scores consider the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, positive surprises beget further positive surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Estimate revisions offer an indication of what analysts are thinking about the short-term prospects of a firm. Estimate revisions are based on the statistical significance of a firm’s last two quarterly earnings surprises and the percentage change in its consensus estimate for the current fiscal year over the past month and past three months.

Solventum Corporation has a Earnings Estimate Score of 74, which is Positive. IDEXX Laboratories, Inc. has a Earnings Estimate Score of 53, which is Neutral.

The Earnings Estimate Revisions Grade Winner: Solventum Corporation

As you can clearly see from the Earnings Estimate Revisions Grade breakdown above, Solventum Corporation has a better Earnings Estimate Revisions Grade than IDEXX Laboratories, Inc.. For those who are specifically looking for companies with better short-term prospects when compared to other companies in the same industry, Solventum Corporation could be a good stock to invest in. However, it’s important to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Solventum Corporation, IDEXX Laboratories and Inc. Grades

In addition to Estimate Revisions, Growth and Momentum, A+ Investor also provides grades for Value and Quality.

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. Specifically, the quality grade is the percentile rank of the composite of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and F-Score.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Solventum Corporation, IDEXX Laboratories and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Solventum Corporation, IDEXX Laboratories or Inc. Stock?

Overall, Solventum Corporation stock has a Growth Score of 73, Momentum Score of 73 and Estimate Revisions Score of 74.

IDEXX Laboratories, Inc. stock has a Growth Score of 100, Momentum Score of 43 and Estimate Revisions Score of 53.

Comparing Solventum Corporation, IDEXX Laboratories and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.